Business Description
Shin Nippon Biomedical Laboratories Ltd
ISIN : JP3379950003
Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.41 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.77 | |||||
| Debt-to-EBITDA | 4.77 | |||||
| Interest Coverage | 19.59 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.84 | |||||
| Beneish M-Score | -2.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.5 | |||||
| 3-Year EBITDA Growth Rate | 17.4 | |||||
| 3-Year EPS without NRI Growth Rate | 20.3 | |||||
| 3-Year Book Growth Rate | 29.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 8.28 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23 | |||||
| 9-Day RSI | 34.52 | |||||
| 14-Day RSI | 41.17 | |||||
| 6-1 Month Momentum % | -13.87 | |||||
| 12-1 Month Momentum % | -25.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.31 | |||||
| Quick Ratio | 0.78 | |||||
| Cash Ratio | 0.45 | |||||
| Days Inventory | 301.91 | |||||
| Days Sales Outstanding | 71.06 | |||||
| Days Payable | 14.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.18 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| 3-Year Dividend Growth Rate | 115.4 | |||||
| Forward Dividend Yield % | 4.26 | |||||
| 5-Year Yield-on-Cost % | 104.32 | |||||
| Shareholder Yield % | -10.52 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.88 | |||||
| Operating Margin % | 10.65 | |||||
| Net Margin % | 16.34 | |||||
| FCF Margin % | -24.63 | |||||
| ROE % | 14.39 | |||||
| ROA % | 6.37 | |||||
| ROIC % | 3.81 | |||||
| 3-Year ROIIC % | 3.17 | |||||
| ROC (Joel Greenblatt) % | 21.97 | |||||
| ROCE % | 12.08 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.43 | |||||
| Forward PE Ratio | 17.74 | |||||
| PE Ratio without NRI | 12.11 | |||||
| Shiller PE Ratio | 21.18 | |||||
| PEG Ratio | 0.5 | |||||
| PS Ratio | 2.03 | |||||
| PB Ratio | 1.56 | |||||
| Price-to-Tangible-Book | 1.56 | |||||
| Price-to-Operating-Cash-Flow | 25.25 | |||||
| EV-to-EBIT | 11.93 | |||||
| EV-to-EBITDA | 11.93 | |||||
| EV-to-Revenue | 2.5 | |||||
| EV-to-FCF | -10.58 | |||||
| Price-to-Projected-FCF | 1.36 | |||||
| Price-to-Median-PS-Value | 1 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.36 | |||||
| Price-to-Graham-Number | 0.79 | |||||
| Earnings Yield (Greenblatt) % | 8.38 | |||||
| FCF Yield % | -12.99 | |||||
| Forward Rate of Return (Yacktman) % | 21.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shin Nippon Biomedical Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 162.026 | ||
| EPS (TTM) (€) | 0.642 | ||
| Beta | -0.25 | ||
| Volatility % | 19.93 | ||
| 14-Day RSI | 41.17 | ||
| 14-Day ATR (€) | 0.107635 | ||
| 20-Day SMA (€) | 7.495 | ||
| 12-1 Month Momentum % | -25.13 | ||
| 52-Week Range (€) | 6.25 - 11.9 | ||
| Shares Outstanding (Mil) | 41.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shin Nippon Biomedical Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shin Nippon Biomedical Laboratories Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shin Nippon Biomedical Laboratories Ltd Frequently Asked Questions
What is Shin Nippon Biomedical Laboratories Ltd(FRA:YB3)'s stock price today?
The current price of FRA:YB3 is €7.20. The 52 week high of FRA:YB3 is €11.90 and 52 week low is €6.25.
When is next earnings date of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3)?
The next earnings date of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is .
Does Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) pay dividends? If so, how much?
The Dividend Yield %  of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is 4.18% (As of Today), Highest Dividend Payout Ratio of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) was 0.47. The lowest was 0.06. And the median was 0.14. The  Forward Dividend Yield % of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is 4.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers